ACC: Ticagrelor Monotherapy Cuts Bleeding Risk in Acute Coronary Syndrome

MONDAY, April 8, 2024-- Treatment with ticagrelor alone results in a lower rate of clinically relevant bleeding compared with ticagrelor and aspirin among patients with an acute coronary syndrome who had percutaneous coronary intervention and...